Table 1 Shift of Delayed Luminescence spectral emission as function of the treatments.

From: Synergic pro-apoptotic effects of Ferulic Acid and nanostructured lipid carrier in glioblastoma cells assessed through molecular and Delayed Luminescence studies

U-87 MG

(DLI450 + DLI550 + DLI650)/DLIvis

+PBS

87.8% ± 1.9

+DMSO

91.0% ± 2.6

+NLC

66.2% ± 2.7

+FA

98.1% ± 2.5

+FA-NLC

68.2% ± 2.5

  1. Percentage ratio of the sum of DL-integral values obtained by using the pass band filters centred at 450 nm, 550 nm, 650 nm to the respective DL-integral acquired in the visible range (350–850 nm). Data are expressed as mean ± S.E. of the values of at least three biological replicates in triplicate.
Back to article page